Multimodal ocular imaging in Proteus syndrome
- PMID: 36113118
- PMCID: PMC10469497
- DOI: 10.1177/11206721221125852
Multimodal ocular imaging in Proteus syndrome
Abstract
In this report we illustrate the ophthalmologic assessment of two patients affected by Proteus Syndrome (PS), an extremely rare genetic disorder. Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen. Case #2 describes a 20 year old female patient referred to our Ophthalmology Department for a routine ophthalmologic evaluation after being treated for 3 years with Miransertib (an experimental AKT-pathway inhibitor). Both patients underwent a complete ophthalmologic examination and a multimodal imaging evaluation. The multimodal imaging approach has revealed useful to evaluate both cases in detail and to keep track of disease evolution over time, moreover providing helpful features to further characterize this rare syndrome.
Keywords: Proteus syndrome; limbal dermoid cyst; miransertib; myopic chorioretinopathy; optic nerve drusen.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Biesecker LG, Sapp JC, et al. Proteus Syndrome. In: Adam MP, Ardinger HH, Pagon RA. (eds) GeneReviews®. Seattle: University of Washington, 1993–2021: 2–12. http://www.ncbi.nlm.nih.gov/books/NBK99495/ (accessed 8 November 2021). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
